国际生物医学工程杂志
國際生物醫學工程雜誌
국제생물의학공정잡지
INTERNATIONAL JOURNAL OF BIOMEDICAL ENGINEERING
2010年
2期
65-69,前插1
,共6页
王海燕%宋丽萍%朱敦皖%周波%刘珍宝%楼莎%冷希岗
王海燕%宋麗萍%硃敦皖%週波%劉珍寶%樓莎%冷希崗
왕해연%송려평%주돈환%주파%류진보%루사%랭희강
内皮祖细胞%逆转录病毒载体%组织因子途径抑制因子
內皮祖細胞%逆轉錄病毒載體%組織因子途徑抑製因子
내피조세포%역전록병독재체%조직인자도경억제인자
Endothelial progenitor cells%Retroviral vector%Tissue factor pathway inhibitor
目的 构建双顺反子表达人组织因子途径抑制因子(TFPI)与绿色荧光蛋白(GFP)的逆转录病毒表达载体pMSCV-TFPI-IRES-GFP,并观察其在大鼠内皮祖细胞(EPCs)中的表达,为进一步研究TEPI在预防血管再狭窄中的作用奠定基础.方法 将人全长TFPI cDNA亚克隆到逆转录病毒载体pMSCV-IRES-GFP中,获得定向插入重组子pMSCV-TFPI-IRES-GFP,采用酶切图谱分析和测序进行鉴定.用磷酸钙法经293T细胞包装,收集病毒上清,感染EPCs.用荧光显微镜和流式细胞术观察感染后细胞内GFP表达情况.RT-PCR检测EPCs中TFPI mRNA的表达水平,ELISA法检测EPCs细胞培养上清中TFPI蛋白的含量.结果 经限制性内切酶酶切图谱分析证实重组病毒中含有人TFPI的cDNA片段,基因测序结果与Genebank中TFPI cDNA序列相符.荧光显微镜观察及流式细胞仪检测显示,90%以上的感染细胞中存在GFP表达;RT-PCR分析显示,重组病毒感染细胞中TFPI mRNA水平明显增高;ELISA法检测发现,感染重组病毒的EPCs培养上清中有TFPI蛋白表达.结论 本研究成功构建重组pMSCV-TFPI-IRES-GFP真核表达载体,其在EPCs中能够同时表达TFPI和GFP,为TFPI基因结合血管内皮祖细胞进行血管再狭窄防治研究的进一步深入开展奠定了良好实验基础.
目的 構建雙順反子錶達人組織因子途徑抑製因子(TFPI)與綠色熒光蛋白(GFP)的逆轉錄病毒錶達載體pMSCV-TFPI-IRES-GFP,併觀察其在大鼠內皮祖細胞(EPCs)中的錶達,為進一步研究TEPI在預防血管再狹窄中的作用奠定基礎.方法 將人全長TFPI cDNA亞剋隆到逆轉錄病毒載體pMSCV-IRES-GFP中,穫得定嚮插入重組子pMSCV-TFPI-IRES-GFP,採用酶切圖譜分析和測序進行鑒定.用燐痠鈣法經293T細胞包裝,收集病毒上清,感染EPCs.用熒光顯微鏡和流式細胞術觀察感染後細胞內GFP錶達情況.RT-PCR檢測EPCs中TFPI mRNA的錶達水平,ELISA法檢測EPCs細胞培養上清中TFPI蛋白的含量.結果 經限製性內切酶酶切圖譜分析證實重組病毒中含有人TFPI的cDNA片段,基因測序結果與Genebank中TFPI cDNA序列相符.熒光顯微鏡觀察及流式細胞儀檢測顯示,90%以上的感染細胞中存在GFP錶達;RT-PCR分析顯示,重組病毒感染細胞中TFPI mRNA水平明顯增高;ELISA法檢測髮現,感染重組病毒的EPCs培養上清中有TFPI蛋白錶達.結論 本研究成功構建重組pMSCV-TFPI-IRES-GFP真覈錶達載體,其在EPCs中能夠同時錶達TFPI和GFP,為TFPI基因結閤血管內皮祖細胞進行血管再狹窄防治研究的進一步深入開展奠定瞭良好實驗基礎.
목적 구건쌍순반자표체인조직인자도경억제인자(TFPI)여록색형광단백(GFP)적역전록병독표체재체pMSCV-TFPI-IRES-GFP,병관찰기재대서내피조세포(EPCs)중적표체,위진일보연구TEPI재예방혈관재협착중적작용전정기출.방법 장인전장TFPI cDNA아극륭도역전록병독재체pMSCV-IRES-GFP중,획득정향삽입중조자pMSCV-TFPI-IRES-GFP,채용매절도보분석화측서진행감정.용린산개법경293T세포포장,수집병독상청,감염EPCs.용형광현미경화류식세포술관찰감염후세포내GFP표체정황.RT-PCR검측EPCs중TFPI mRNA적표체수평,ELISA법검측EPCs세포배양상청중TFPI단백적함량.결과 경한제성내절매매절도보분석증실중조병독중함유인TFPI적cDNA편단,기인측서결과여Genebank중TFPI cDNA서렬상부.형광현미경관찰급류식세포의검측현시,90%이상적감염세포중존재GFP표체;RT-PCR분석현시,중조병독감염세포중TFPI mRNA수평명현증고;ELISA법검측발현,감염중조병독적EPCs배양상청중유TFPI단백표체.결론 본연구성공구건중조pMSCV-TFPI-IRES-GFP진핵표체재체,기재EPCs중능구동시표체TFPI화GFP,위TFPI기인결합혈관내피조세포진행혈관재협착방치연구적진일보심입개전전정료량호실험기출.
Objective To construct the recombinant retroviral vector capable of expressing human tissue factor pathway inhibitor and GFP in rat endothelial progenitor cells (EPCs). Methods Full length TFPI cDNA obtained from pIRES-TFPI by PCR amplification was digested with EcoRI and Xhol restriction enzymes and subsequently inserted into pMSCV-IRES-GFP expression vector to create the recombinant bicistronic retroviral vector pMSCV- TFPI- IRES -GFP encoding both TFPI and GFP . The recombinant plasmid was identified with restrictive endonuclease digestion and DNA sequencing. The recombinant plasmid was transfected into 293T and the supernatant containing packaged recombinant retroviral particles was collected and used to infect the EPCs isolated from rat bone marrow. TFPI mRNA was measured by RT-PCR and the amount of TFPI protein secreted from the transfected cells was determined by ELISA. GFP expression in the infected cells was analyzed by fluorescent microscopy and fluorescence activated cell sorting (FACS). Results Restriction endonuclease mapping and DNA sequencing confirmed the in-frame insertion of TFPI cDNA into the constructed vectorpMSCV-TFPI-IRES-GFP. Both RT-PCR and ELISA analysis demonstrated increased TFPI expression in the EPCs infected with pMSCV-TFPI-IRES-GFP. FACS analysis demonstrated that the transduction efficiency of EPCs with pMSCV-TFPI-IRES-GFP in vitro was over 90%. Conclusion pMSCV-TFPI-IRES-GFP could be effectively expressed in cultured EPCs and may provide a useful tool for further study on the application of TFPI in the prevention of restenosis.